| David W Wallace, MD MBA | |
|
515 Hospital Dr, Suite 1, Shelbyville, KY 40065-1640 | |
| (502) 633-3525 | |
| (502) 633-8075 |
| Full Name | David W Wallace |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 43 Years |
| Location | 515 Hospital Dr, Shelbyville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376532168 | NPI | - | NPPES |
| 0100487 | Other | UHC | |
| P00872496 | Other | KY | RR MEDICARE |
| 000000048268 | Other | KY | ANTHEM |
| 64220544 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 22054 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home | Louisville, KY | Home health agency |
| Jewish Hospital - Shelbyville | Shelbyville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
News Archive
In 2004 University of Kansas researchers Linda Heitzman-Powell and Jay Buzhardt had the bold idea of training parents of children with autism to use an intervention based on the science of applied behavior analysis (ABA) to help them increase their children's independent skills and reduce problem behaviors.
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Every year, heart disease claims an estimated 7 million lives, according to the World Health Organization. Scientists have struggled to pinpoint the precise genes behind this complex disease. Now, however, they have a new research ally: the designer rat.
› Verified 5 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
In 2004 University of Kansas researchers Linda Heitzman-Powell and Jay Buzhardt had the bold idea of training parents of children with autism to use an intervention based on the science of applied behavior analysis (ABA) to help them increase their children's independent skills and reduce problem behaviors.
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Every year, heart disease claims an estimated 7 million lives, according to the World Health Organization. Scientists have struggled to pinpoint the precise genes behind this complex disease. Now, however, they have a new research ally: the designer rat.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David W Wallace, MD MBA 100 E Liberty St Ste 800, Louisville, KY 40202-1428 Ph: (502) 633-3525 | David W Wallace, MD MBA 515 Hospital Dr, Suite 1, Shelbyville, KY 40065-1640 Ph: (502) 633-3525 |
News Archive
In 2004 University of Kansas researchers Linda Heitzman-Powell and Jay Buzhardt had the bold idea of training parents of children with autism to use an intervention based on the science of applied behavior analysis (ABA) to help them increase their children's independent skills and reduce problem behaviors.
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Every year, heart disease claims an estimated 7 million lives, according to the World Health Organization. Scientists have struggled to pinpoint the precise genes behind this complex disease. Now, however, they have a new research ally: the designer rat.
› Verified 5 days ago
Dr. Ron E Creque Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Stonecrest Road, Suite 3, Shelbyville, KY 40065 Phone: 502-633-5565 Fax: 502-633-5154 | |
Dr. Ronald E Waldridge Sr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 60 Mack Walters Rd, Shelbyville, KY 40065 Phone: 502-633-4622 Fax: 502-633-6925 | |
Leticia Kathryn Allen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 60 Mack Walters Rd, Shelbyville, KY 40065 Phone: 502-633-4622 Fax: 502-633-6925 | |
Dr. William J Jackson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 148 Midland Blvd, Shelbyville, KY 40065 Phone: 502-647-1958 Fax: 502-647-1940 | |
James R Smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Hospital Dr, Ste 1, Shelbyville, KY 40065 Phone: 502-633-3525 Fax: 502-633-8075 | |
Dr. Jena Thomas Ruxer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4000 |